Search results
HanxBio announces the publication of a research paper in Scientific Reports on preclinical...
FOX 59 Indianapolis· 4 days agoHanxBio today announced that it has published a research article titled "Narazaciclib, a novel...
FDA grants breakthrough status for Kura Oncology's AML drug candicate By Investing.com
Investing.com· 5 days agoFood and Drug Administration (FDA) has awarded Breakthrough Therapy Designation to its drug...
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Proactive Investors· 24 hours agoAfter re-manufacturing the lentivirus, Hemogenyx successfully addressed the FDA's concerns and...
Kura Oncology Gets Breakthrough Designation For Leukemia Therapy
Market Watch· 5 days agoThe San Diego-based biopharmaceutical company said the U.S. Food and Drug Administration had granted ziftomenib the status as a potential treatment for relapsed/refractory ...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 5 days agoFood and Drug Administration (FDA) for the treatment of patients with relapsed/refractory (R/R) NPM1-mutant acute myeloid leukemia ...
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 3 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 4 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
BioLineRx (NASDAQ:BLRX) Upgraded by StockNews.com to Sell
ETF DAILY NEWS· 3 days agoStockNews.com upgraded shares of BioLineRx (NASDAQ:BLRX – Free Report) to a sell rating in a research note published on Tuesday morning. Separately, HC Wainwright restated a buy rating and issued ...
CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers
MedPage Today· 3 days agoA strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 2 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
